A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. Keeping that in mind, here are three low-volatility stocks to steer clear of and a few better alternatives. MGP Ingredients (MGPI) Rolling One-Year Beta: 0.79 Headquartered in Atchison, Kansas, MGP Ingredients (NASDAQ:MGPI) is a leading supplier of high-quality ingredients to the food and beverage industry Why Should You Dump MGPI? Annual sales declines of 2.8% for the past three years show its products struggled to connect with the market Sales are projected to tank by 19.8% over the next 12 months as its demand continues evaporating Operating profits fell over the last year as its sales dropped and it struggled to adjust its fixed costs At $33 per share, MGP Ingredients trades at 12.4x forward P/E. Read our free research report to see why you should think twice about including MGPI in your portfolio, it’s free. Casella Waste Systems (CWST) Rolling One-Year Beta: 0.44 Starting with the founder picking up garbage with a pickup truck he purchased using savings from high school, Casella (NASDAQ:CWST) offers waste management services for businesses, residents, and the government. Why Are We Cautious About CWST? Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth Expenses have increased as a percentage of revenue over the last five years as its operating margin fell by 4 percentage points Issuance of new shares partly offset its revenue growth over the last two years as its earnings per share were flat Casella Waste Systems’s stock price of $114.68 implies a valuation ratio of 98.1x forward P/E. Check out our free in-depth research report to learn more about why CWST doesn’t pass our bar. Privia Health (PRVA) Rolling One-Year Beta: 0.68 Operating in 13 states and the District of Columbia with over 4,300 providers serving more than 4.8 million patients, Privia Health (NASDAQ:PRVA) is a technology-driven company that helps physicians optimize their practices, improve patient experiences, and transition to value-based care models. Why Does PRVA Give Us Pause? Modest revenue base of $1.80 billion gives it less fixed cost leverage and fewer distribution channels than larger companies Low free cash flow margin of 4.6% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders Negative returns on capital show management lost money while trying to expand the business Story Continues Privia Health is trading at $25.02 per share, or 29.3x forward P/E. If you’re considering PRVA for your portfolio, see our FREE research report to learn more. Stocks We Like More Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. View Comments
3 Dawdling Stocks with Mounting Challenges
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...